Prevalence and mechanism of triazole resistance in Aspergillus fumigatus in a referral chest hospital in Delhi, India and an update of the situation in Asia

Frontiers in Microbiology

Volumn 6, Issue MAY, 2015, Pages

  Chowdhary, Anuradha ^a   Sharma, Cheshta ^a   Kathuria, Shallu ^a   Hagen, Ferry ^b   Meis, Jacques F ^b,c  

^a UNIVERSITY OF DELHI   (India)

^b CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Asia; G54E; India; Microsatellite typing; TR34 L98H; Triazole resistant A. fumigatus

Indexed keywords

AMPHOTERICIN B; ANIDULAFUNGIN; BETA TUBULIN; CALMODULIN; CASPOFUNGIN; ECHINOCANDIN; HEXACONAZOLE; ISAVUCONAZOLE; ITRACONAZOLE; MICAFUNGIN; POSACONAZOLE; TRIADIMEFON; TRIAZOLE; VORICONAZOLE;

ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ASIA; ASPERGILLUS FUMIGATUS; ASPERGILLUS TERREUS; CHRONIC OBSTRUCTIVE LUNG DISEASE; GENE MUTATION; GENE SEQUENCE; HOSPITAL; HUMAN; INDIA; INVASIVE ASPERGILLOSIS; LUNG ASPERGILLOSIS; MUTATIONAL ANALYSIS; PREVALENCE; REAL TIME POLYMERASE CHAIN REACTION; SHORT TANDEM REPEAT;

ASPERGILLUS; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS TERREUS;

EID: 84931267254     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2015.00428     Document Type: Article

References (79)

1. Abdolrasoulia, A., Rhodes, J., Beale, M. A., Hagen, F., Rogers, T. R., Chowdhary, A., et al. (2015). Genomic context of azole-resistance mutations in Aspergillus fumigatus using whole-genome sequencing. mBio 6, (in press).
2. Agarwal, R., Chakrabarti, A., Shah, A., Gupta, D., Meis, J. F., Guleria, R., et al. (2013). Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria. Clin. Exp. Allergy 43, 850-873. doi: 10.1111/cea.12141.
3. Ahmad, S., Joseph, L., Hagen, F., Meis, J. F., and Khan, Z. (2015). Concomitant occurrence of itraconazole-resistant and-susceptible strains of Aspergillus fumigatus in routine cultures. J. Antimicrob. Chemother. 70, 412-415. doi: 10.1093/jac/dku410.
4. Ahmad, S., Khan, Z., Hagen, F., and Meis, J. F. (2014). Occurrence of triazole-resistant Aspergillus fumigatus with TR34/L98H mutations in outdoor and hospital environment in Kuwait. Environ. Res. 133, 20-26. doi: 10.1016/j.envres.2014.05.009.
5. Alastruey-Izquierdo, A., Mellado, E., Peláez, T., Pemán, J., Zapico, S., Alvarez, M., et al. (2013). Population-based survey of filamentous fungi and antifungal resistance in Spain (FILPOP Study). Antimicrob. Agents Chemother. 57, 3380-3387. doi: 10.1128/AAC.00383-13.
6. Albarrag, A. M., Anderson, M. J., Howard, S. J., Robson, G. D., Warn, P. A., Sanglard, D., et al. (2011). Interrogation of related clinical pan-azole-resistant Aspergillus fumigatus strains: G138C, Y431C, and G434C single nucleotide polymorphisms in cyp51A, upregulation of cyp51A, and integration and activation of transposon Atf1 in the cyp51A promoter. Antimicrob. Agents Chemother. 55, 5113-5121. doi: 10.1128/AAC.00517-11.
7. Arendrup, M. C., Mavridou, E., Mortensen, K. L., Snelders, E., Frimodt-Møller, N., Khan, H., et al. (2010). Development of azole resistance in Aspergillus fumigatus during azole therapy associated with change in virulence. PLoS ONE 5:e10080. doi: 10.1371/journal.pone.0010080.
8. Asano, M., Kano, R., Makimura, K., Hasegawa, A., and Kamata, H. (2011). Molecular typing and in-vitro activity of azoles against clinical isolates of Aspergillus fumigatus and A. niger in Japan. J. Infect. Chemother. 17, 483-486. doi: 10.1007/s10156-010-0202-1.
9. Ascioglu, S., Rex, J. H., de Pauw, B., Bennett, J. E., Bille, J., Crokaert, F., et al. (2002). Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin. Infect. Dis. 34, 7-14. doi: 10.1086/323335.
10. Astvad, K. M., Jensen, R. H., Hassan, T. M., Mathiasen, E. G., Thomsen, G. M., Pedersen, U. G., et al. (2014). First detection of TR46/Y121F/T289A and TR34/L98H alterations in Aspergillus fumigatus isolates from azole-naive patients in Denmark despite negative findings in the environment. Antimicrob. Agents Chemother. 58, 5096-5101. doi: 10.1128/AAC.02855-14.
11. Badali, H., Vaezi, A., Haghani, I., Yazdanparast, S. A., Hedayati, M. T., Mousavi, B., et al. (2013). Environmental study of azole-resistant Aspergillus fumigatus with TR34/L98H mutations in the cyp51A gene in Iran. Mycoses 56, 659-663. doi: 10.1111/myc.12089.
12. Baddley, J. W., Marr, K. A., Andes, D. R., Walsh, T. J., Kauffman, C. A., Kontoyiannis, D. P., et al. (2009). Patterns of susceptibility of Aspergillus isolates recovered from patients enrolled in the Transplant-Associated Infection Surveillance Network. J. Clin. Microbiol. 47, 3271-3275. doi: 10.1128/JCM.00854-09.
13. Bader, O., Weig, M., Reichard, U., Lugert, R., Kuhns, M., Christner, M., et al. (2013). cyp51A-based mechanisms of Aspergillus fumigatus azole drug resistance present in clinical samples from Germany. Antimicrob. Agents Chemother. 57, 3513-3517. doi: 10.1128/AAC.00167-13.
14. Bueid, A., Howard, S. J., Moore, C. B., Richardson, M. D., Harrison, E., Bowyer, P., et al. (2010). Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009. J. Antimicrob. Chemother. 65, 2116-2118. doi: 10.1093/jac/dkq279.
15. Burgel, P. R., Baixench, M. T., Amsellem, M., Audureau, E., Chapron, J., Kanaan, R., et al. (2012). High prevalence of azole-resistant Aspergillus fumigatus in adults with cystic fibrosis exposed to itraconazole. Antimicrob. Agents Chemother. 56, 869-874. doi: 10.1128/AAC.05077-11.
16. Chen, J., Li, H., Li, R., Bu, D., and Wan, Z. (2005). Mutations in the cyp51A gene and susceptibility to itraconazole in Aspergillus fumigatus serially isolated from a patient with lung aspergilloma. J. Antimicrob. Chemother. 55, 31-37. doi: 10.1093/jac/dkh507.
17. Chowdhary, A., Agarwal, K., Kathuria, S., Singh, P. K., Roy, P., Gaur, S. N., et al. (2013a). Clinical significance of filamentous basidiomycetes illustrated by isolates of the novel opportunist Ceriporia lacerata from the human respiratory tract. J. Clin. Microbiol. 51, 585-590. doi: 10.1128/JCM.02943-12.
18. Chowdhary, A., Kathuria, S., Xu, J., and Meis, J. F. (2013b). Emergence of azole-resistant Aspergillus fumigatus strains due to agricultural azole use creates an increasing threat to human health. PLoS Pathog. 9:e1003633. doi: 10.1371/journal.ppat.1003633.
19. Chowdhary, A., Kathuria, S., Randhawa, H. S., Gaur, S. N., Klaassen, C. H., and Meis, J. F. (2012a). Isolation of multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR/L98H mutations in the cyp51A gene in India. J. Antimicrob. Chemother. 67, 362-366. doi: 10.1093/jac/dkr443.
20. Chowdhary, A., Kathuria, S., Xu, J., Sharma, C., Sundar, G., Singh, P. K., et al. (2012b). Clonal expansion and emergence of environmental multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR34/L98H mutations in the cyp51A gene in India. PLoS ONE 7:e52871. doi: 10.1371/journal.pone.0052871.
21. Chowdhary, A., Sharma, C., Kathuria, S., Hagen, F., and Meis, J. F. (2014a). Azole-resistant Aspergillus fumigatus with the environmental TR46/Y121F/T289A mutation in India. J. Antimicrob. Chemother. 69, 555-557. doi: 10.1093/jac/dkt397.
22. Chowdhary, A., Sharma, C., van den Boom, M., Yntema, J. B., Hagen, F., Verweij, P. E., et al. (2014b). Multi-azole-resistant Aspergillus fumigatus in the environment in Tanzania. J. Antimicrob. Chemother. 69, 2979-2983. doi: 10.1093/jac/dku259.
23. Chowdhary, A., Sharma, C., Hagen, F., and Meis, J. F. (2014c). Exploring azole antifungal drug resistance in Aspergillus fumigatus with special reference to resistance mechanisms. Future Microbiol. 9, 697-711. doi: 10.2217/fmb.14.27.
24. Clinical and laboratory Standards Institute [CLSI]. (2008). Reference Method for Broth Dilution. (Antifungal) Susceptibility Testing of Filamentous Fungi; Approved Standard-Second Edition, M38-A2. Wayne, PA: CLSI.
25. Denning, D. W., Venkateswarlu, K., Oakley, K. L., Anderson, M. J., Manning, N. J., Stevens, D. A., et al. (1997). Itraconazole resistance in Aspergillus fumigatus. Antimicrob. Agents Chemother. 41, 1364-1368.
26. De Pauw, B., Walsh, T. J., Donnelly, J. P., Stevens, D. A., Edwards, J. E., Calandra, T., et al. (2008). Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin. Infect. Dis. 46, 1813-1821. doi: 10.1086/588660.
27. de Valk, H. A., Meis, J. F., Curfs, I. M., Muehlethaler, K., Mouton, J. W., and Klaassen, C. H. (2005). Use of a novel panel of nine short tandem repeats for exact and high-resolution fingerprinting of Aspergillus fumigatus isolates. J. Clin. Microbiol. 43, 4112-4120. doi: 10.1128/JCM.43.8.4112-4120.2005.
28. Diaz-Guerra, T. M., Mellado, E., Cuenca-Estrella, M., and Rodriguez-Tudela, J. L. (2003). A point mutation in the 14-alpha-sterol demethylase gene cyp51A contributes to itraconazole resistance in Aspergillus fumigatus. Antimicrob. Agents Chemother. 47, 1120-1124. doi: 10.1128/AAC.47.3.1120-1124.2003.
29. Escribano, P., Peláez, T., Muñoz, P., Bouza, E., and Guinea, J. (2013). Is azole resistance in Aspergillus fumigatus a problem in Spain? Antimicrob. Agents Chemother. 57, 2815-2820. doi: 10.1128/AAC.02487-12.
30. Escribano, P., Recio, S., Peláez, T., González-Rivera, M., Bouza, E., and Guinea, J. (2012). In vitro acquisition of secondary azole resistance in Aspergillus fumigatus isolates after prolonged exposure to itraconazole: presence of heteroresistant populations. Antimicrob. Agents Chemother. 56, 174-178. doi: 10.1128/AAC.00301-11.
31. Espinel-Ingroff, A., Chowdhary, A., Gonzalez, G. M., Lass-Flörl, C., Martin-Mazuelos, E., Meis, J. F., et al. (2013). Multicenter study of isavuconazole MIC distributions and epidemiological cutoff values for Aspergillus spp. for the CLSI M38-A2 broth microdilution method. Antimicrob. Agents Chemother. 57, 3823-3828. doi: 10.1128/AAC.00636-13.
32. Espinel-Ingroff, A., Fothergill, A., Fuller, J., Johnson, E., Pelaez, T., and Turnidge, J. (2011a). Wild-type MIC distributions and epidemiological cutoff values for caspofungin and Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document). Antimicrob. Agents Chemother. 55, 2855-2859. doi: 10.1128/AAC.01730-10.
33. Espinel-Ingroff, A., Cuenca-Estrella, M., Fothergill, A., Fuller, J., Ghannoum, M., Johnson, E., et al. (2011b). Wild-type MIC distributions and epidemiological cutoff values for amphotericin B and Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document). Antimicrob. Agents Chemother. 55, 5150-5154. doi: 10.1128/AAC.00686-11.
34. Fischer, J., van Koningsbruggen-Rietschel, S., Rietschel, E., Vehreschild, M. J., Wisplinghoff, H., Krönke, M., et al. (2014). Prevalence and molecular characterization of azole resistance in Aspergillus spp. isolates from German cystic fibrosis patients. J. Antimicrob. Chemother. 69, 1533-1536. doi: 10.1093/jac/dku009.
35. Hagiwara, D., Takahashi, H., Watanabe, A., Takahashi-Nakaguchi, A., Kawamoto, S., Kamei, K., et al. (2014). Whole-genome comparison of Aspergillus fumigatus strains serially isolated from patients with aspergillosis. J. Clin. Microbiol. 52, 4202-4209. doi: 10.1128/JCM.01105-14.
36. Hall, T. A. (1999). BioEdit: a user-friendly biological sequence alignment editor and analysisprogram for Windows 95/98/NT. Nucleic Acids. Symp. Ser. 41, 95-98. doi: 10.14601/Phytopathol_Mediterr-14998u1.29.
37. Hamprecht, A., Buchheidt, D., Vehreschild, J. J., Cornely, O. A., Spiess, B., Plum, G., et al. (2012). Azole-resistant invasive aspergillosis in a patient with acute myeloid leukaemia in Germany. Euro. Surveill. 17, 20262.
38. Howard, S. J., Cerar, D., Anderson, M. J., Albarrag, A., Fisher, M. C., Pasqualotto, A. C., et al. (2009). Frequency and evolution of azole resistance in Aspergillus fumigatus associated with treatment failure. Emerg. Infect. Dis. 15, 1068-1076. doi: 10.3201/eid1507.090043.
39. Howard, S. J., Lass-Flörl, C., Cuenca-Estrella, M., Gomez-Lopez, A., and Arendrup, M. C. (2013). Determination of isavuconazole susceptibility of Aspergillus and Candida species by the EUCAST method. Antimicrob. Agents Chemother. 57, 5426-5431. doi: 10.1128/AAC.01111-13.
40. Howard, S. J., Webster, I., Moore, C. B., Gardiner, R. E., Park, S., Perlin, D. S., et al. (2006). Multi-azole resistance in Aspergillus fumigatus. Int. J. Antimicrob. Agents 28, 450-453. doi: 10.1016/j.ijantimicag.2006.08.017.
41. Hsueh, P. R., Lau, Y. J., Chuang, Y. C., Wan, J. H., Huang, W. K., and Shyr, J. M. (2005). Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003. Antimicrob. Agents Chemother. 49, 512-517. doi: 10.1128/AAC.49.2.512-517.2005.
42. Jeurissen, A., Cooreman, S., Van Kerckhoven, W., Van Leemput, J., Vanhove, P., Lagrou, K., et al. (2012). Invasive pulmonary aspergillosis due to a multi-azole resistant Aspergillus fumigatus. Acta Clin. Belg. 67, 46-48.
43. Kano, R., Kohata, E., Tateishi, A., Murayama, S. Y., Hirose, D., Shibata, Y., et al. (2015). Does farm fungicide use induce azole resistance in Aspergillus fumigatus? Med. Mycol. 53, 174-177. doi: 10.1093/mmy/myu076.
44. Kathuria, S., Sharma, C., Singh, P. K., Agarwal, P., Agarwal, K., Hagen, F., et al. (2015). Molecular epidemiology and in-vitro antifungal susceptibility of Aspergillus terreus species complex isolates in Delhi, India: evidence of genetic diversity by amplified fragment length polymorphism and microsatellite typing. PLoS ONE 10:e0118997. doi: 10.1371/journal.pone.0118997.
45. Kidd, S. E., Goeman, E., Meis, J. F., Slavin, M. A., and Verweij, P. E. (2015). Multi-triazole-resistant Aspergillus fumigatus infections in Australia. Mycoses 58, 350-355. doi: 10.1111/myc.12324.
46. Klaassen, C. H., de Valk, H. A., Curfs-Breuker, I. M., and Meis, J. F. (2010). Novel mixed-format real-time PCR assay to detect mutations conferring resistance to triazoles in Aspergillus fumigatus and prevalence of multi-triazole resistance among clinical isolates in the Netherlands. J. Antimicrob. Chemother. 65, 901-905. doi: 10.1093/jac/dkq041.
47. Klaassen, C. H., Gibbons, J. G., Fedorova, N. D., Meis, J. F., and Rokas, A. (2012). Evidence for genetic differentiation and variable recombination rates among Dutch populations of the opportunistic human pathogen Aspergillus fumigatus. Mol. Ecol. 21, 57-70. doi: 10.1111/j.1365-294X.2011.05364.x.
48. Kosmidis, C., and Denning, D. W. (2015). The clinical spectrum of pulmonary aspergillosis. Thorax 70, 270-277. doi: 10.1136/thoraxjnl-2014-206291.
49. Kwon-Chung, K. J., and Sugui, J. A. (2013). Aspergillus fumigatus-what makes the species a ubiquitous human fungal pathogen? PLoS Pathog. 9:e1003743. doi: 10.1371/journal.ppat.1003743.
50. Lavergne, R. A., Morio, F., Favennec, L., Dominique, S., Meis, J. F., Gargala, G., et al. (2015). First description of azole-resistant Aspergillus fumigatus due to TR46/Y121F/T289A mutation in France. Antimicrob. Agents Chemother. (Accepted). doi: 10.1128/AAC.00127-15.
51. Lockhart, S. R., Frade, J. P., Etienne, K. A., Pfaller, M. A., Diekema, D. J., and Balajee, S. A. (2011). Azole resistance in Aspergillus fumigatus isolates from the ARTEMIS global surveillance study is primarily due to the TR/L98H mutation in the cyp51A gene. Antimicrob. Agents Chemother. 55, 4465-4468. doi: 10.1128/AAC.00185-11.
52. Mann, P. A., Parmegiani, R. M., Wei, S. Q., Mendrick, C. A., Li, X., Loebenberg, D., et al. (2003). Mutations in Aspergillus fumigatus resulting in reduced susceptibility to posaconazole appear to be restricted to a single amino acid in the cytochrome P450 14-alpha-demethylase. Antimicrob. Agents Chemother. 47, 577-581. doi: 10.1128/AAC.47.2.577-581.2003.
53. Mellado, E., Garcia-Effron, G., Alcazar-Fuoli, L., Cuenca-Estrella, M., and Rodriguez-Tudela, J. L. (2004). Substitutions at methionine 220 in the 14-alpha-sterol demethylase (cyp51A) of Aspergillus fumigatus are responsible for resistance in vitro to azole antifungal drugs. Antimicrob. Agents Chemother. 48, 2747-2750. doi: 10.1128/AAC.48.7.2747-2750.2004.
54. Mellado, E., Garcia-Effron, G., Alcázar-Fuoli, L., Melchers, W. J., Verweij, P. E., Cuenca-Estrella, M., et al. (2007). A new Aspergillus fumigatus resistance mechanism conferring in vitro cross-resistance to azole antifungals involves a combination of cyp51A alterations. Antimicrob. Agents Chemother. 51, 1897-1904. doi: 10.1128/AAC.01092-06.
55. Morio, F., Aubin, G. G., Danner-Boucher, I., Haloun, A., Sacchetto, E., Garcia-Hermoso, D., et al. (2012). High prevalence of triazole resistance in Aspergillus fumigatus, especially mediated by TR/L98H, in a French cohort of patients with cystic fibrosis. J. Antimicrob. Chemother. 67, 1870-1873. doi: 10.1093/jac/dks160.
56. Mortensen, K. L., Jensen, R. H., Johansen, H. K., Skov, M., Pressler, T., Howard, S. J., et al. (2011). Aspergillus species and other molds in respiratory samples from patients with cystic fibrosis: a laboratory-based study with focus on Aspergillus fumigatus azole resistance. J. Clin. Microbiol. 49, 2243-2251. doi: 10.1128/JCM.00213-11.
57. Mortensen, K. L., Mellado, E., Lass-Flörl, C., Rodriguez-Tudela, J. L., Johansen, H. K., and Arendrup, M. C. (2010). Environmental study of azole-resistant Aspergillus fumigatus and other aspergilli in Austria, Denmark, and Spain. Antimicrob. Agents Chemother. 54, 4545-4549. doi: 10.1128/AAC.00692-10.
58. Pfaller, M., Boyken, L., Hollis, R., Kroeger, J., Messer, S., Tendolkar, S., et al. (2011). Use of epidemiological cutoff values to examine 9-year trends in susceptibility of Aspergillus species to the triazoles. J. Clin. Microbiol. 49, 586-590. doi: 10.1128/JCM.02136-10.
59. Pham, C. D., Reiss, E., Hagen, F., Meis, J. F., and Lockhart, S. R. (2014). Passivesurveillance for azole-resistant Aspergillus fumigatus, United States, 2011-2013. Emerg. Infect. Dis. 20, 1498-1503. doi: 10.3201/eid2009.140142.
60. Prigitano, A., Venier, V., Cogliati, M., De Lorenzis, G., Esposto, M. C., and Tortorano, A. M. (2014). Azole-resistant Aspergillus fumigatus in the environment of northern Italy, May 2011 to June 2012. Euro. Surveill. 19, 20747. doi: 10.2807/1560-7917.ES2014.19.12.20747.
61. Rath, P. M., Buchheidt, D., Spiess, B., Arfanis, E., Buer, J., and Steinmann, J. (2012). First reported case of azole-resistant Aspergillus fumigatus due to the TR/L98H mutation in Germany. Antimicrob. Agents Chemother. 56, 6060-6061. doi: 10.1128/AAC.01017-12.
62. Rocchi, S., Daguindau, E., Grenouillet, F., Deconinck, E., Bellanger, A. P., Garcia-Hermoso, D., et al. (2014). Azole-resistant Aspergillus fumigatus isolate with the TR34/L98H mutation in both a fungicide-sprayed field and the lung of a hematopoietic stem cell transplant recipient with invasive aspergillosis. J. Clin. Microbiol. 52, 1724-1726. doi: 10.1128/JCM.03182-13.
63. Rodriguez-Tudela, J. L., Alcazar-Fuoli, L., Mellado, E., Alastruey-Izquierdo, A., Monzon, A., and Cuenca-Estrella, M. (2008). Epidemiological cutoffs and cross-resistance to azole drugs in Aspergillus fumigatus. Antimicrob. Agents Chemother. 52, 2468-2472. doi: 10.1128/AAC.00156-08.
64. Seyedmousavi, S., Hashemi, S. J., Zibafar, E., Zoll, J., Hedayati, M. T., Mouton, J. W., et al. (2013). Azole-resistant Aspergillus fumigatus, Iran. Emerg. Infect. Dis. 19, 832-834. doi: 10.3201/eid1905.130075.
65. Sharma, C., Hagen, F., Moroti, R., Meis, J. F., and Chowdhary, A. (2015). Triazole resistant Aspergillus fumigatus harbouring G54 mutation: is it de novo or environmentally acquired? J. Glob. Antimicrob. Resist. 3, (in press). doi: 10.1016/j.jgar.2015.01.005.
66. Snelders, E., Huis In 't Veld, R. A., Rijs, A. J., Kema, G. H., Melchers, W. J., and Verweij, P. E. (2009). Possible environmental origin of resistance of Aspergillus fumigatus to medical triazoles. Appl. Environ. Microbiol. 75, 4053-4057. doi: 10.1128/AEM.00231-09.
67. Snelders, E., van der Lee, H. A., Kuijpers, J., Rijs, A. J., Varga, J., Samson, R. A., et al. (2008). Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism. PLoS Med. 5:e219. doi: 10.1371/journal.pmed.0050219.
68. Spiess, B., Postina, P., Reinwald, M., Cornely, O. A., Hamprecht, A., Hoenigl, M., et al. (2014). Incidence of Cyp51A key mutations in Aspergillus fumigatus-A study on primary clinical samples of immunocompromised patients in the period of 1995-2013. PLoS ONE 9:e103113. doi: 10.1371/journal.pone.0103113.
69. Steinmann, J., Hamprecht, A., Vehreschild, M. J., Cornely, O. A., Buchheidt, D., Spiess, B., et al. (2015). Emergence of azole-resistant invasive aspergillosis in HSCT recipients in Germany. J. Antimicrob. Chemother. 70, 1522-1526. doi: 10.1093/jac/dku566.
70. Stensvold, C., Jørgensen, L., and Arendrup, M. (2012). Azole-resistant invasive aspergillosis: relationship to agriculture. Curr. Fungal Infect. Rep. 6, 178-191. doi: 10.1007/s12281-012-0097-7.
71. Tashiro, M., Izumikawa, K., Hirano, K., Ide, S., Mihara, T., Hosogaya, N., et al. (2012a). Correlation between triazole treatment history and susceptibility in clinically isolated Aspergillus fumigatus. Antimicrob. Agents Chemother. 56, 4870-4875. doi: 10.1128/AAC.00514-12.
72. Tashiro, M., Izumikawa, K., Minematsu, A., Hirano, K., Iwanaga, N., Ide, S., et al. (2012b). Antifungal susceptibilities of Aspergillus fumigatus clinical isolates obtained in Nagasaki, Japan. Antimicrob. Agents Chemother. 56, 584-587. doi: 10.1128/AAC.05394-11.
73. van der Linden, J. W., Arendrup, M. C., Warris, A., Lagrou, K., Pelloux, H., Hauser, P. M., et al. (2015). Prospective multicentre international surveillance of azole resistance in Aspergillus fumigatus. Emerg. Infect. Dis. (in press). doi: 10.3201/eid2106.140717.
74. van der Linden, J. W., Camps, S. M., Kampinga, G. A., Arends, J. P., Debets-Ossenkopp, Y. J., Haas, P. J., et al. (2013). Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles. Clin. Infect. Dis. 57, 513-520. doi: 10.1093/cid/cit320.
75. van der Linden, J. W., Snelders, E., Kampinga, G. A., Rijnders, B. J., Mattsson, E., Debets-Ossenkopp, Y. J., et al. (2011). Clinical implications of azole resistance in Aspergillus fumigatus, The Netherlands, 2007-2009. Emerg. Infect. Dis. 17, 1846-1854. doi: 10.3201/eid1710.110226.
76. Verweij, P. E., Mellado, E., and Melchers, W. J. (2007). Multiple-triazole-resistant aspergillosis. N. Engl. J. Med. 356, 1481-1483. doi: 10.1056/NEJMc061720.
77. Verweij, P. E., Snelders, E., Kema, G. H., Mellado, E., and Melchers, W. J. (2009). Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use? Lancet Infect. Dis. 9, 789-795. doi: 10.1016/S1473-3099(09)70265-8.
78. Wang, D. Y., Gricourt, M., Arné, P., Thierry, S., Seguin, D., Chermette, R., et al. (2014). Mutations in the Cyp51A gene and susceptibility to itraconazole in Aspergillus fumigatus isolated from avian farms in France and China. Poult. Sci. 93, 12-15. doi: 10.3382/ps.2013-03541.
79. Xu, H., Chen, W., Li, L., Wan, Z., Li, R., and Liu, W. (2010). Clinical itraconazole-resistant strains of Aspergillus fumigatus, isolated serially from a lung aspergilloma patient with pulmonary tuberculosis, can be detected with real-time PCR method. Mycopathologia 169, 193-199. doi: 10.1007/s11046-009-9249-x.